News
-
-
-
COMMUNIQUÉ DE PRESSE
Phase III GRAPPA trial supports ATLG (Grafalon®) as standard of care in matched unrelated donor stem cell transplantation
Phase III GRAPPA trial results show ATLG (Grafalon®) superiority in unrelated donor stem cell transplantation. Lower mortality and infection rates support its continued use as standard care -
-
-
-
-
COMMUNIQUÉ DE PRESSE
Giotto.ai Launches Free Cloud Access to Its AI System
Giotto.ai launches free cloud access to its general-purpose AI system, aiming to provide advanced intelligence to all users worldwide. The Swiss AI lab's new Giotto Cloud offers powerful AI capabilities without usage restrictions -
-
